Quest Diagnostics Inc/ US74834L1008 /
| 11/6/2024 10:10:00 PM | Chg. +1.08 | Volume | Bid11:25:36 PM | Ask11:25:36 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 155.18USD | +0.70% | 804,078 Turnover: 78.1 mill. |
153.52Bid Size: 100 | 157.38Ask Size: 100 | 17.32 bill.USD | 1.83% | 20.45 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 7.59 USD | -6.30% |
| EPS Diluted: | 7.49 USD | -6.02% |
| Revenues per Share: | 57.11 USD | -35.67% |
| Book Value per Share: | 39.15 USD | -26.51% |
| Cash Flow per Share: | 7.85 USD | -49.12% |
| Dividend per Share: | 2.84 USD | 7.58% |
| Total | in mill. | |
| Revenues: | 9,252.00 USD | -6.38% |
| Net Income: | 854.00 USD | -9.73% |
| Operating Cash Flow: | 1,272.00 USD | - |
| Cash and Cash Equivalents: | 686.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 20.45 | 18.17 |
| P/S Ratio: | 2.72 | 2.41 |
| P/BV ratio: | 3.96 | 3.52 |
| P/CF Ratio: | 19.76 | 17.56 |
| PEG: | -3.25 | -2.89 |
| Earnings Yield: | 4.89% | 5.50% |
| Dividend Yield: | 1.83% | 2.06% |
| Market Capitalization | ||
| Market Capitalization: | 17.32 bill. USD | 22.34 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 111.62 mill. | |
Profitability
| Gross Profit Margin: | 33.00% |
| EBIT Margin: | 13.64% |
| Net Profit Margin: | 9.23% |
| Return on Equity: | 13.47% |
| Return on Assets: | 6.09% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.38% |
| Liquidity II / Quick Ratio: | 1.04% |
| Liquidity III / Current Ratio: | 1.31% |
| Debt / Equity Ratio: | 0.74% |
| Dynam. Debt / Equity Ratio: | 603.77% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
